Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative effectiveness of dopamine agonists and monoamine oxidase type-B inhibitors for Parkinson’s disease: a multiple treatment comparison meta-analysis
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-25
DOI
10.1007/s00228-020-02961-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease
- (2018) C. D. Binde et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson’s Disease: a Network Meta-Analysis
- (2018) Bao-Dong Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Cognitive Effects of Rasagiline in Mild-to-Moderate Stage Parkinson's Disease Without Dementia
- (2017) Laura L. Frakey et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
- (2017) Fabrizio Stocchi et al. NEUROLOGY
- Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1
- (2017) Robert A. Hauser et al. Journal of Parkinsons Disease
- Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson’s Disease: A Network Meta-Analysis
- (2017) Chuanjun Zhuo et al. Scientific Reports
- Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease
- (2016) Robert A Hauser et al. BMC Neurology
- Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson’s disease
- (2016) Sun Ju Chung et al. EXPERT OPINION ON PHARMACOTHERAPY
- Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease
- (2015) Daphne Robakis et al. CNS DRUGS
- Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial
- (2015) A. Antonini et al. EUROPEAN JOURNAL OF NEUROLOGY
- A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson's disease patients
- (2015) P. Barone et al. EUROPEAN JOURNAL OF NEUROLOGY
- A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson's Disease-Associated Chronic Pain
- (2015) Olivier Rascol et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease
- (2015) Thien Thien Lim et al. MOVEMENT DISORDERS
- Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease
- (2015) Robert A. Hauser et al. JAMA Neurology
- Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis
- (2015) Ingunn Fride Tvete et al. PLoS One
- Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
- (2014) Masahiro Nomoto et al. JOURNAL OF NEUROLOGY
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Rotigotine vs ropinirole in advanced stage Parkinson's disease: A double-blind study
- (2014) Yoshikuni Mizuno et al. PARKINSONISM & RELATED DISORDERS
- Initial management of Parkinson's disease
- (2014) C. G. Goetz et al. BMJ-British Medical Journal
- Efficacy and safety of rasagiline as an adjunct to levodopa treatment in Chinese patients with Parkinson's disease: a randomized, double-blind, parallel-controlled, multi-centre trial
- (2013) Lina Zhang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
- (2013) Anthony HV Schapira et al. LANCET NEUROLOGY
- Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease
- (2013) A. Storch et al. NEUROLOGY
- The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: A multicenter, double-blind, randomized, placebo-controlled study
- (2013) Zhenxin Zhang et al. PARKINSONISM & RELATED DISORDERS
- Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials
- (2011) Cristina Sampaio et al. MOVEMENT DISORDERS
- Milestones in Parkinson's disease therapeutics
- (2011) Olivier Rascol et al. MOVEMENT DISORDERS
- The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study
- (2011) Hasmet A. Hanagasi et al. MOVEMENT DISORDERS
- Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial
- (2011) W. Poewe et al. NEUROLOGY
- Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial
- (2011) A. H. V. Schapira et al. NEUROLOGY
- Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2010) Paolo Barone et al. LANCET NEUROLOGY
- Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
- (2010) Robert A. Hauser et al. MOVEMENT DISORDERS
- Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER)
- (2010) Claudia Trenkwalder et al. MOVEMENT DISORDERS
- Twice-daily, low-dose pramipexole in early Parkinson's disease: A randomized, placebo-controlled trial
- (2010) Karl Kieburtz et al. MOVEMENT DISORDERS
- Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease
- (2010) Ray L. Watts et al. MOVEMENT DISORDERS
- A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
- (2009) C. Warren Olanow et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now